Compare Stocks: BWAY, ESTA, NVCR, and BFLY

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BFLY Butterfly Network	$7.49 -0.5%	$8.01	$1.47 ▼ $10.05	$2.00B	2.08	4.29 million shs	4.12 million shs
BWAY Brainsway	$14.41 +1.8%	$15.13	$7.14 ▼ $17.40	$569.34M	1.25	112,222 shs	128,995 shs
ESTA Establishment Labs	$74.51 -1.0%	$82.69	$36.53 ▼ $97.59	$2.24B	1.05	387,202 shs	317,080 shs
NVCR NovoCure	$15.63 -7.2%	$16.91	$9.82 ▼ $21.45	$1.96B	1.01	1.14 million shs	995,543 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BFLY Butterfly Network	-0.40%	-2.16%	-22.91%	+32.60%	+370.75%
BWAY Brainsway	+1.77%	+0.91%	-5.94%	-1.91%	+81.03%
ESTA Establishment Labs	-1.04%	-0.55%	-0.73%	-12.45%	+90.03%
NVCR NovoCure	-7.24%	-12.34%	-9.71%	-11.74%	+23.46%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BFLY Butterfly Network	$7.49 -0.5%	$8.01	$1.47 ▼ $10.05	$2.00B	2.08	4.29 million shs	4.12 million shs
BWAY Brainsway	$14.41 +1.8%	$15.13	$7.14 ▼ $17.40	$569.34M	1.25	112,222 shs	128,995 shs
ESTA Establishment Labs	$74.51 -1.0%	$82.69	$36.53 ▼ $97.59	$2.24B	1.05	387,202 shs	317,080 shs
NVCR NovoCure	$15.63 -7.2%	$16.91	$9.82 ▼ $21.45	$1.96B	1.01	1.14 million shs	995,543 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BFLY Butterfly Network	-0.40%	-2.16%	-22.91%	+32.60%	+370.75%
BWAY Brainsway	+1.77%	+0.91%	-5.94%	-1.91%	+81.03%
ESTA Establishment Labs	-1.04%	-0.55%	-0.73%	-12.45%	+90.03%
NVCR NovoCure	-7.24%	-12.34%	-9.71%	-11.74%	+23.46%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BFLY Butterfly Network	2.40	Hold	$5.56	-25.68% Downside
BWAY Brainsway	2.71	Moderate Buy	$18.20	26.30% Upside
ESTA Establishment Labs	2.78	Moderate Buy	$100.25	34.55% Upside
NVCR NovoCure	2.14	Hold	$21.20	35.64% Upside

Current Analyst Ratings Breakdown

Latest BWAY, ESTA, NVCR, and BFLY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/8/2026	BWAY Brainsway	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$19.00
9/1/2026	ESTA Establishment Labs	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$103.00
8/31/2026	BWAY Brainsway	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$17.00 ➝ $19.00
8/27/2026	NVCR NovoCure	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
8/19/2026	BWAY Brainsway	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy (B-) ➝ Hold (C+)
8/13/2026	ESTA Establishment Labs	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$92.00
8/13/2026	BWAY Brainsway	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$18.00 ➝ $18.80
8/12/2026	BWAY Brainsway	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$18.00 ➝ $20.00
8/11/2026	BWAY Brainsway	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/7/2026	ESTA Establishment Labs	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$84.00 ➝ $95.00
8/6/2026	ESTA Establishment Labs	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$105.00

(Data available from 9/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BFLY Butterfly Network	$112.14M	17.77	N/A	N/A	$0.77 per share	9.72
BWAY Brainsway	$52.22M	11.10	$0.24 per share	60.44	$1.87 per share	7.71
ESTA Establishment Labs	$245.82M	9.03	N/A	N/A	$0.81 per share	91.99
NVCR NovoCure	$655.35M	2.78	N/A	N/A	$3.04 per share	5.14

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BFLY Butterfly Network	-$77.06M	-$0.29	N/A	N/A	N/A	-66.74%	-33.99%	-22.96%	10/30/2026 (Estimated)
BWAY Brainsway	$7.57M	$0.44	32.75	25.28	N/A	15.65%	12.74%	8.17%	11/10/2026 (Estimated)
ESTA Establishment Labs	-$51.06M	-$1.31	N/A	7,451.00	N/A	-15.82%	-196.69%	-10.73%	11/4/2026 (Estimated)
NVCR NovoCure	-$136.23M	-$1.30	N/A	N/A	N/A	-21.25%	-44.00%	-15.85%	10/29/2026 (Estimated)

Latest BWAY, ESTA, NVCR, and BFLY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2026	Q2 2026	BWAY Brainsway	$0.10	$0.14	+$0.04	$0.07	$16.54 million	$17.11 million
8/6/2026	Q2 2026	ESTA Establishment Labs	-$0.3368	-$0.39	-$0.0532	-$0.39	$65.79 million	$67.54 million
7/30/2026	Q2 2026	BFLY Butterfly Network	-$0.0350	-$0.01	+$0.0250	-$0.05	$29.16 million	$32.61 million
7/23/2026	Q2 2026	NVCR NovoCure	-$0.3315	-$0.13	+$0.2015	-$0.13	$172.44 million	$183.58 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BFLY Butterfly Network	N/A	N/A	N/A	N/A	N/A
BWAY Brainsway	N/A	N/A	N/A	N/A	N/A
ESTA Establishment Labs	N/A	N/A	N/A	N/A	N/A
NVCR NovoCure	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BFLY Butterfly Network	N/A	4.06	3.06
BWAY Brainsway	N/A	3.59	3.27
ESTA Establishment Labs	12.11	3.84	2.52
NVCR NovoCure	0.58	2.89	2.70

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BFLY Butterfly Network	37.85%
BWAY Brainsway	30.11%
ESTA Establishment Labs	72.91%
NVCR NovoCure	84.61%

Insider Ownership

Company	Insider Ownership
BFLY Butterfly Network	21.99%
BWAY Brainsway	19.00%
ESTA Establishment Labs	9.99%
NVCR NovoCure	6.55%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BFLY Butterfly Network	460	266.29 million	207.73 million	Optionable
BWAY Brainsway	120	40.21 million	32.57 million	Not Optionable
ESTA Establishment Labs	1,004	29.80 million	26.83 million	Optionable
NVCR NovoCure	1,605	116.45 million	108.82 million	Optionable

BWAY, ESTA, NVCR, and BFLY Headlines

Recent News About These Companies

NovoCure Announces Routine Board Transition After Director Retirement

September 9 at 7:31 AM | tipranks.com

NovoCure (NASDAQ:NVCR) Trading Down 7.5% - Here's What Happened

September 8 at 3:19 PM | marketbeat.com

Novocure Reports Patient Data Exposure in Cybersecurity Incident

September 7 at 12:15 PM | zacks.com

Novocure says data exposed in cybersecurity incident

September 4, 2026 | massdevice.com

NovoCure Limited $NVCR Holdings Reduced by Bank of America Corp DE

September 3, 2026 | marketbeat.com

Cybersecurity breach at Novocure raises alarm after exposure of confidential patient data

September 2, 2026 | ciso.economictimes.indiatimes.com

Novocure data breach affects more than 1,400 cancer patients

September 2, 2026 | bleepingcomputer.comB

NovoCure drops as customer information leaked in cyberattack

September 1, 2026 | msn.com

Oncology firm Novocure says cyberattack exposed US patient records

September 1, 2026 | reuters.com

NovoCure (NASDAQ:NVCR) Rating Lowered to "Hold" at Wall Street Zen

August 29, 2026 | marketbeat.com

Wall Street Analysts See a 50.86% Upside in NovoCure (NVCR): Can the Stock Really Move This High?

August 28, 2026 | zacks.com

NovoCure Limited (NASDAQ:NVCR) Receives Average Recommendation of "Hold" from Analysts

August 28, 2026 | marketbeat.com

NovoCure (NASDAQ:NVCR) Shares Down 4% - What's Next?

August 21, 2026 | marketbeat.com

Are You Looking for a Top Momentum Pick? Why NovoCure (NVCR) is a Great Choice

August 20, 2026 | zacks.com

Wall Street Analysts Think NovoCure (NVCR) Could Surge 53.68%: Read This Before Placing a Bet

August 12, 2026 | zacks.com

Sei Investments Co. Buys 89,839 Shares of NovoCure Limited $NVCR

August 12, 2026 | marketbeat.com

First Trust Advisors LP Invests $1.03 Million in NovoCure Limited $NVCR

August 11, 2026 | marketbeat.com

4 Healthcare Stocks to Watch as Defensive Demand Strengthens

August 7, 2026 | zacks.com

NovoCure (NVCR) Upgraded to Buy: What Does It Mean for the Stock?

July 27, 2026 | zacks.com

Wall Street Analysts Believe NovoCure (NVCR) Could Rally 46.63%: Here's is How to Trade

July 27, 2026 | zacks.com

Unlocking NovoCure (NVCR) International Revenues: Trends, Surprises, and Prospects

July 27, 2026 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BWAY, ESTA, NVCR, and BFLY Company Descriptions

Butterfly Network NYSE:BFLY

$7.48 -0.04 (-0.47%)

Closing price 09/9/2026 03:59 PM Eastern

Extended Trading

$7.55 +0.06 (+0.86%)

As of 09/9/2026 07:59 PM Eastern

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

Brainsway NASDAQ:BWAY

$14.41 +0.25 (+1.77%)

Closing price 09/9/2026 04:00 PM Eastern

Extended Trading

$14.42 +0.00 (+0.03%)

As of 09/9/2026 04:43 PM Eastern

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

Establishment Labs NASDAQ:ESTA

$74.51 -0.78 (-1.04%)

Closing price 09/9/2026 04:00 PM Eastern

Extended Trading

$74.46 -0.05 (-0.06%)

As of 09/9/2026 07:30 PM Eastern

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

NovoCure NASDAQ:NVCR

$15.63 -1.22 (-7.24%)

Closing price 09/9/2026 04:00 PM Eastern

Extended Trading

$15.53 -0.10 (-0.67%)

As of 09/9/2026 07:32 PM Eastern

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BWAY, ESTA, NVCR, and BFLY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BWAY, ESTA, NVCR, and BFLY Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BWAY, ESTA, NVCR, and BFLY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BWAY, ESTA, NVCR, and BFLY Company Descriptions

Butterfly Network NYSE:BFLY

Brainsway NASDAQ:BWAY

Establishment Labs NASDAQ:ESTA

NovoCure NASDAQ:NVCR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BWAY, ESTA, NVCR, and BFLY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BWAY, ESTA, NVCR, and BFLY Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BWAY, ESTA, NVCR, and BFLY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BWAY, ESTA, NVCR, and BFLY Company Descriptions

Butterfly Network NYSE:BFLY

Brainsway NASDAQ:BWAY

Establishment Labs NASDAQ:ESTA

NovoCure NASDAQ:NVCR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools